About Granules India
Granules India is a company based in Hyderabad (India) founded in 1984 by Krishna Prasad Chigurupati. The company has 6,170 employees as of March 31, 2024. Granules India has completed 2 acquisitions, including Auctus Pharma and Senn Chemicals.
- Headquarter Hyderabad, India
- Employees 6170 as on 31 Mar, 2024
- Founders Krishna Prasad Chigurupati
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Granules India Limited
-
Annual Revenue
$524.62 M (USD)-0.55as on Mar 31, 2025
-
Net Profit
$58.76 M (USD)23.74as on Mar 31, 2025
-
EBITDA
$112.6 M (USD)8.23as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
6170
as on Mar 31, 2024
-
Investments & Acquisitions
Auctus Pharma
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Granules India
Granules India is a publicly listed company on the NSE with ticker symbol GRANULES in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Granules India
Unlock access to complete
Unlock access to complete
Leadership Team
24 people
Human Resources and Administration
13 people
Software Development Team
11 people
Product Management Team
9 people
Finance and Accounting
8 people
Operations Team
6 people
General Team
5 people
Manager Team
4 people
Unlock access to complete
Funding Insights of Granules India
Detailed funding history for Granules India
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Granules India
Granules India has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Auctus Pharma and Senn Chemicals.
Investment portfolio details for Granules India
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Active pharmaceutical ingredients are manufactured by Auctus Pharma.
|
Locked | Locked | 2000 | Locked | |
|
Contract manufacturing for peptides, amino acid derivatives, carbohydrates, small molecules, etc
|
Locked | Locked | 1963 | Locked |
Complete acquisition details for Granules India
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Granules India
Detailed financials for Granules India
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Granules India Comparisons
Peer comparison for Granules India
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Granules India
Detailed competitors of Granules India
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Granules India
Complete news archive for Granules India
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Granules India
Granules India was founded in 1984.
Granules India is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
KVS Ram Rao is the current CEO of Granules India.
As of Mar 31, 2024, the latest employee count at Granules India is 6,170.
Annual revenue of Granules India is $524.62M as on Mar 31, 2025.
CDMO focused on manufacturing of active pharmaceutical ingredients. It offers a wide range of products include Paracetamol, Ibuprofen, Metformin, Guaifenesin, Methocarbamol, Pharmaceutical Formulation Intermediates and Finished Dosages.
Yes, Granules India is publicly traded on NSE under the ticker symbol GRANULES.
Granules India has made 2 acquisitions, including Auctus Pharma, and Senn Chemicals.
The ticker symbol of Granules India is GRANULES on NSE.